Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Yamanouchi claims antidiabetic agents

May 17, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

SKB discloses fibrinogen and vitronectin antagonists in patent literature

May 17, 1996

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Teijin claims anticoagulant peptides

May 17, 1996

Lilly reports agents for septic shock

May 17, 1996

Fujisawa isolates cGMP PDE inhibitor from Pseudomonas

May 17, 1996

Merck & Co. claims class III antiarrhythmics

May 17, 1996

FK-409 claimed as portal hypertension Rx

May 17, 1996

Endothelin antagonists reported by Shionogi

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...